WeVote
Log In

Bill

RB

Bill

S 3952

Revises law concerning patient referrals to substance use disorder treatment facilities, recovery residences, and clinical laboratories.*

2024-2025 Regular Session Introduced by Renee Burgess and 4 co-sponsors

New Jersey bill modernizes referral protocols for substance abuse treatment facilities and recovery residences to improve patient access and ensure appropriate care placement.

Substituted by A3973 (1R)
#drugabuse #healthfac
0
WeVote Research Nonpartisan
Bill Summary · S 3952

Legislative bill overview

S 3952 revises New Jersey's regulations governing how patients are referred to substance use disorder (SUD) treatment facilities, recovery residences, and clinical laboratories. The bill has been substituted by Assembly Bill A3973, indicating significant amendments were made during the legislative process. The measure aims to modernize or clarify the referral system for addiction treatment services in the state.

Why is this important

Substance use disorder treatment access is a critical public health issue, and referral pathways directly affect whether patients receive timely, appropriate care. Clearer referral regulations can reduce barriers to treatment, prevent inappropriate facility placements, and ensure quality standards across SUD treatment providers. This is particularly relevant given the ongoing opioid crisis and New Jersey's efforts to expand addiction recovery resources.

Potential points of contention

  • Financial incentives and conflicts of interest: Regulations on referrals often involve concerns about whether referral sources receive financial benefits, potentially creating incentives to refer patients to specific facilities rather than those best suited to their needs
  • Recovery residence standards: Defining which facilities qualify as legitimate recovery residences versus unregulated housing arrangements, and whether regulations are stringent enough to protect vulnerable patients
  • Clinical laboratory referrals: Questions about whether labs are being unnecessarily referred or if testing standards adequately protect patient interests and insurance coverage

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.